paclitaxel - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial AUST R: 328527 Active ingredients: paclitaxel Dosage form: Injection, powder for Sponsor: Cipla Australia Pty Ltd Phone: 0396964413	From 05 Feb 2026 to 21 Aug 2026	Shortage status: Current Availability: Limited Availability Reason: Manufacturing Management action: An alternative brand is available.
PACLITAXEL ACCORD paclitaxel 300 mg/50 mL concentrated injection vial AUST R: 219556 Active ingredients: paclitaxel Dosage form: Injection, concentrated Sponsor: Accord Healthcare Pty Ltd Phone: 1800 222 673	From 09 Apr 2026 to 30 Jun 2026	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: Alternative brands are available.
ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial AUST R: 133500 Active ingredients: paclitaxel Dosage form: Injection, powder for Sponsor: Abraxis Bioscience Australia Pty Ltd Phone: 1300 798 820	From 05 Mar 2026 to 16 Mar 2026	Shortage status: Resolved Availability: Available Reason: Unexpected increase in demand due to other sponsors unable to supply
ANZATAX paclitaxel 30mg/5mL injection vial AUST R: 50578 Active ingredients: paclitaxel Dosage form: Injection, concentrated Sponsor: Pfizer Australia Pty Ltd Phone: 1800-675-229	Deletion from market: 06 Oct 2025	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Other strengths are available.